Precision psychiatry, also known as personalized psychiatry or precision medicine in psychiatry, is a cutting-edge approach that aims to tailor psychiatric treatment to individual patients based on their unique characteristics, including genetic makeup, neurobiological markers, and environmental factors. Traditional psychiatric treatments often adopt a one-size-fits-all approach, which may not be effective for all patients and can lead to significant side effects. Precision psychiatry leverages advancements in genetics, neuroimaging, and data analytics to identify biomarkers associated with psychiatric disorders and treatment response. For example, researchers have identified genetic variations that influence an individual's likelihood of responding to certain medications or experiencing adverse effects. By analyzing these genetic markers, clinicians can optimize medication selection and dosages to maximize efficacy and minimize side effects for each patient. Additionally, neuroimaging techniques such as fMRI and EEG provide valuable insights into brain function and connectivity, allowing clinicians to identify neural patterns associated with specific psychiatric symptoms or treatment outcomes. This information can inform treatment decisions and help monitor progress over time. Furthermore, precision psychiatry emphasizes the importance of considering environmental factors such as stress, trauma, and lifestyle habits in understanding psychiatric disorders and designing personalized treatment plans. By taking a holistic approach to patient care, clinicians can address underlying contributors to mental illness and tailor interventions accordingly. Overall, precision psychiatry represents a paradigm shift in psychiatric practice, moving towards more personalized and effective treatments for individuals with mental health conditions. By harnessing the power of genetics, neurobiology, and environmental factors, clinicians can provide targeted interventions that improve outcomes and enhance the overall well-being of patients.
Title : Perception and individuality
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : ACE-dependent Alzheimer’s Disease (AD)
Sergei M Danilov, University of Illinois, United States
Title : Essential roles, mechanisms and consequences of vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Neuroimaging by evaluation nerverenovate and neuroplasticity of acupuncture in children with cerebral palsy
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : The foundation and architecture of Personalized & Precision Medicine (PPM) in clinical neurology: Towards curative and neurodegenerative disease-modifying treatment for multiple sclerosis
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Who cares …… for the carers
Jaqueline Tuppen, COGS Club, United Kingdom